查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520433

2024-2032 年体外大肠直肠癌筛检测试市场报告（按产品、影像类型、最终用户和地区）

In-vitro Colorectal Cancer Screening Tests Market Report by Product, Imaging Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球体外大肠直肠癌筛检测试市场规模达9.972亿美元。

体外大肠直肠癌筛检测试是用于检测腺瘤、息肉和大肠直肠癌症状的诊断程序。大肠直肠癌是一种以大肠、结肠和直肠细胞异常生长为特征的疾病。粪便潜血 (FOB)、侧流免疫、转铁蛋白测定、甲基化基因、生物标记和癒创木脂 FOB 粪便试验是一些常用的筛检试验。体外结直肠癌筛检测试涉及使用摄影机捕捉消化道影像并将其传输到绑在患者腰部的记录器上。它们是微创的，可以帮助及时发现癌症。因此，体外大肠直肠癌筛检测试在诊所、医院和诊断实验室广泛进行。

体外大肠直肠癌筛检测试市场趋势：

大众大肠癌盛行率的增加是推动市场成长的关键因素之一。此外，人们对早期发现和及时治疗癌症的好处的认识不断提高，正在对市场成长产生积极影响。各种技术进步，例如将基因测试整合到癌症筛检测试中，正在推动市场成长。这些测试有助于早期发现、制定治疗计划、防止癌细胞扩散并最大限度地降低相关疾病的风险。与此一致的是，人们越来越倾向于使用微创（MI）诊断程序来检测大肠癌，这有利于市场的成长。其他因素，包括老年人口的增加（更容易患此类疾病）、医疗保健行业的显着改善，以及政府强制实施癌症筛检测试的各种倡议，预计将推动市场成长。

本报告回答的关键问题

  • 2023年全球大肠直肠癌体外筛检测试市场规模有多大？
  • 2024-2032年全球体外大肠直肠癌筛检测试市场的预期成长率是多少？
  • COVID-19 对全球大肠直肠癌体外筛检测试市场有何影响？
  • 推动全球体外大肠直肠癌筛检测试市场的关键因素是什么？
  • 基于该产品的全球体外大肠直肠癌筛检测试市场的细分情况如何？
  • 根据影像类型，全球体外大肠直肠癌筛检测试市场的细分如何？
  • 基于最终用户的全球体外大肠直肠癌筛检测试市场的细分情况如何？
  • 全球大肠直肠癌体外筛检测试市场的关键区域有哪些？
  • 全球体外大肠直肠癌筛检测试市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球体外大肠直肠癌筛检测试市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 粪便潜血测试
    • 市场走向
    • 关键环节
      • 癒创木脂 FOB 粪便测试
      • 免疫 FOB 凝集试验
      • 侧流免疫 FOB 测试
      • 免疫 FOB ELISA 测试
    • 市场预测
  • 生物标记测试
    • 市场走向
    • 关键环节
      • 肿瘤 M2-PK 粪便测试
      • 转铁蛋白测定
    • 市场预测
  • CRC DNA 筛检测试
    • 市场走向
    • 关键环节
      • 甲基化基因检测
      • 小组 DNA 测试
    • 市场预测

第 7 章：市场区隔：依影像类型

  • 大肠镜检查
    • 市场走向
    • 市场预测
  • 直肠镜检查
    • 市场走向
    • 市场预测
  • CT扫描
    • 市场走向
    • 市场预测
  • 超音波
    • 市场走向
    • 市场预测
  • 核磁共振成像
    • 市场走向
    • 市场预测
  • 正子断层扫描
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 诊断实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Beckman Coulter Inc. (Danaher Corporation)
    • Eiken Chemical Co. Ltd.
    • Epigenomics AG
    • Exact Sciences Corporation
    • Hemosure Inc.
    • Immunostics Inc. (Boditech Med Inc.)
    • Medline Industries LP
    • Merck KGaA
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • R-Biopharm AG
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112024A5383

The global in-vitro colorectal cancer screening tests market size reached US$ 997.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,590.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.

In-Vitro Colorectal Cancer Screening Tests Market Trends:

The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global In-vitro colorectal cancer screening tests market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, imaging type and end user.

Breakup by Product:

Fecal Occult Blood Tests

Guaiac FOB Stool Test

Immuno-FOB Agglutination Test

Lateral Flow Immuno-FOB Test

Immuno-FOB ELISA Test

Biomarker Tests

Tumor M2-PK Stool Test

Transferrin Assays

CRC DNA Screening Tests

Methylated Gene Testing

Panel DNA Tests

Breakup by Imaging Type:

Colonoscopy

Proctoscopy

CT Scan

Ultrasound

MRI

PET Scan

Breakup by End User:

Hospitals

Clinics

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global in-vitro colorectal cancer screening tests market in 2023?
  • 2. What is the expected growth rate of the global in-vitro colorectal cancer screening tests market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global in-vitro colorectal cancer screening tests market?
  • 4. What are the key factors driving the global in-vitro colorectal cancer screening tests market?
  • 5. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the product?
  • 6. What is the breakup of the global in-vitro colorectal cancer screening tests market based on the imaging type?
  • 7. What is the breakup of the global in-vitro colorectal cancer screening tests market based on end user?
  • 8. What are the key regions in the global in-vitro colorectal cancer screening tests market?
  • 9. Who are the key players/companies in the global in-vitro colorectal cancer screening tests market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vitro Colorectal Cancer Screening Tests Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Fecal Occult Blood Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Guaiac FOB Stool Test
      • 6.1.2.2 Immuno-FOB Agglutination Test
      • 6.1.2.3 Lateral Flow Immuno-FOB Test
      • 6.1.2.4 Immuno-FOB ELISA Test
    • 6.1.3 Market Forecast
  • 6.2 Biomarker Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tumor M2-PK Stool Test
      • 6.2.2.2 Transferrin Assays
    • 6.2.3 Market Forecast
  • 6.3 CRC DNA Screening Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Methylated Gene Testing
      • 6.3.2.2 Panel DNA Tests
    • 6.3.3 Market Forecast

7 Market Breakup by Imaging Type

  • 7.1 Colonoscopy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Proctoscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 CT Scan
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Ultrasound
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 MRI
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 PET Scan
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Eiken Chemical Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Epigenomics AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Exact Sciences Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hemosure Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Immunostics Inc. (Boditech Med Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medline Industries LP
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 R-Biopharm AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Sysmex Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Major Drivers and Challenges
  • Figure 2: Global: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Product (in %), 2023
  • Figure 5: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Imaging Type (in %), 2023
  • Figure 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by End User (in %), 2023
  • Figure 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Region (in %), 2023
  • Figure 8: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: In-vitro Colorectal Cancer Screening Tests (Fecal Occult Blood Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: In-vitro Colorectal Cancer Screening Tests (Biomarker Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: In-vitro Colorectal Cancer Screening Tests (CRC DNA Screening Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: In-vitro Colorectal Cancer Screening Tests (Colonoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: In-vitro Colorectal Cancer Screening Tests (Proctoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: In-vitro Colorectal Cancer Screening Tests (CT Scan) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: In-vitro Colorectal Cancer Screening Tests (Ultrasound) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: In-vitro Colorectal Cancer Screening Tests (MRI) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: In-vitro Colorectal Cancer Screening Tests (PET Scan) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: In-vitro Colorectal Cancer Screening Tests (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: In-vitro Colorectal Cancer Screening Tests (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: In-vitro Colorectal Cancer Screening Tests (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: In-vitro Colorectal Cancer Screening Tests (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: In-vitro Colorectal Cancer Screening Tests Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: In-vitro Colorectal Cancer Screening Tests Industry: SWOT Analysis
  • Figure 84: Global: In-vitro Colorectal Cancer Screening Tests Industry: Value Chain Analysis
  • Figure 85: Global: In-vitro Colorectal Cancer Screening Tests Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Imaging Type (in Million US$), 2024-2032
  • Table 4: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: In-vitro Colorectal Cancer Screening Tests Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: In-vitro Colorectal Cancer Screening Tests Market: Competitive Structure
  • Table 7: Global: In-vitro Colorectal Cancer Screening Tests Market: Key Players